Home / Wiki / M / Molecular Diagnostics

Molecular Diagnostics

Investment and Capital MarketsUpdated 16 Nov 2026

Molecular diagnostics is the branch of laboratory medicine that detects and monitors disease by analysing biological molecules, chiefly DNA and RNA and also proteins, in a sample of blood, saliva or tissue. Its main techniques are the polymerase chain reaction, which copies a target stretch of genetic material until it can be detected, and gene sequencing, the core method of genomics. The tests identify infections, inherited conditions and the mutations that drive a tumour, often earlier and more precisely than older methods. Research tests are extending the field to proteomics, metabolomics and combined multiomics signals.

The industry consists of instrument makers, suppliers of test kits and laboratories that run tests as a service. Its economics depend on regulatory clearance, evidence that a test changes treatment, and the prices that insurers and public health systems agree to pay. The sector is a regular component of healthcare funds and of thematic investing in precision medicine.

Last updated 16 Nov 2026